# Adialante

Source: https://onco.cc/companies/adialante/  
OnCo record `adialante` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Adialante has redesigned MRI so it fits in a mobile clinic and is paid per scan, aiming to bring MRI cancer screening to any medical site, starting with prostate cancer.

## Summary

Adialante is rebuilding MRI hardware, physics and reconstruction algorithms from the ground up to create a mobile, low-cost scanner offered to clinics on a flat per-scan fee with no capital purchase, with the stated purpose of making MRI-based cancer screening available at any clinic rather than only at hospitals with a fixed scanner. Its first target is prostate cancer, where MRI before biopsy is already guideline practice, with other cancers to follow. The company is a Spring 2026 YC company; the scanner is in development and has no regulatory clearance recorded.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: San Francisco, CA
- Type: imaging
- Website: https://www.adialante.com

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/adialante
- Official website: https://www.adialante.com

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/), [Imaging](https://onco.cc/fronts/imaging/)
- technologies: [MRI](https://onco.cc/technologies/mri/), [Whole-body MRI](https://onco.cc/technologies/whole-body-mri/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/adialante.json